Document Type
Article
Publication Date
12-2021
Publication Title
Mammalian genome : official journal of the International Mammalian Genome Society
Keywords
JMG
JAX Source
Mamm Genome 2021 Dec; 32(6):415-426
Volume
32
Issue
6
First Page
415
Last Page
426
ISSN
1432-1777
PMID
34477920
DOI
https://doi.org/10.1007/s00335-021-09910-3
Grant
CA034196
Abstract
Rhomboid proteases, first discovered in Drosophila, are intramembrane serine proteases. Members of the rhomboid protein family that are catalytically deficient are known as inactive rhomboids (iRhoms). iRhoms have been implicated in wound healing, cancer, and neurological disorders such as Alzheimer's and Parkinson's diseases, inflammation, and skin diseases. The past decade of mouse research has shed new light on two key protein domains of iRhoms-the cytosolic N-terminal domain and the transmembrane dormant peptidase domain-suggesting new ways to target multiple intracellular signaling pathways. This review focuses on recent advances in uncovering the unique functions of iRhom protein domains in normal growth and development, growth factor signaling, and inflammation, with a perspective on future therapeutic opportunities.
Recommended Citation
Burzenski LM,
Low BE,
Kohar V,
Shultz LD,
Wiles MV,
Hosur V.
Inactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models. Mamm Genome 2021 Dec; 32(6):415-426
Comments
We thank Iiro Taneli Helenius for critical reading of the manuscript. We also thank Zoe Reifsnyder for preparation of figures.
This article is licensed under a Creative Commons Attri-
bution 4.0 International License.